医疗管理在血管异常中的作用
Michael H White1,2,3,4, C Matthew Hawkins3,4
1Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia.
Seminars in interventional radiology
|November 11, 2024
概括
血管异常治疗已经从手术发展到向药物治疗. 这种转变通过更有效地解决复杂疾病,改善了患者的治疗结果和生活质量.
科学领域:
- 血管医学 血管医学
- 药理学 药理学是指药理学的学科.
- 遗传学 遗传学 是一个
背景情况:
- 血管异常存在复杂的诊断和治疗挑战.
- 传统的治疗方法 (手术,支持性护理) 往往导致患者的显著发病率和死亡率.
- 对潜在的遗传和分子途径的有限理解历史上阻碍了有效的治疗.
研究的目的:
- 审查血管异常治疗策略的演变.
- 突出新药疗法选择的影响.
- 强调在管理这些条件时采用多学科方法的重要性.
主要方法:
- 对血管异常的历史和当前治疗方法的审查.
- 分析了解这些疾病的遗传和分子基础的进展.
- 讨论药物治疗和血液管理的整合.
主要成果:
- 对血管异常的向药物治疗选择的显著扩大.
- 更好地理解和管理相关的血液学异常.
- 转向多学科,多模式的治疗策略.
结论:
- 现代药物疗法为患有血管异常的患者提供了改善的结果.
- 对于所有涉及的专家来说,全面了解医疗管理至关重要.
- 患者现在可以从多种不同的治疗选择中受益,从而改善生活质量和降低发病率.
相关概念视频
Mitral Regurgitation III: Medical Management
4
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
4
Esophageal Varices-II: Clinical Features and Management
46
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
46
Mitral Valve Prolapse III: Nursing Management
5
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
5
Rheumatic Heart Disease III: Medical Management
3
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
3
Mitral Valve Prolapse II: Assessment and Management
3
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
3
Myocarditis III: Medical Management
2
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
2


